| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.27 | 7e-06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.21 | 7e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-05 |